The compound has long been investigated inside the patent literature for its anxiolytic properties and lessened sedative, hypnotic, and ataxic facet-effects, but it does not look like certified for healthcare use. ?ukasik-G?ebocka et alA single pharmacokinetics examine showed that a dose of 0.5 mg flubromazolam induced powerful sedative effects tha